What Synaptic Systems does

Synaptic Systems GmbH, founded in 1997 by scientists from the Max Planck Institute for Multidisciplinary Sciences in Göttingen, Germany, develops, produces, and sells research antibodies and related reagents under the SYSY Antibodies brand. Its 1,935+ product catalog spans primary antibodies (polyclonal, monoclonal, and recombinant formats targeting synaptic, neuronal, immune, and cancer-relevant proteins), secondary antibodies, single-domain FluoTags, DNA-PAINT imaging kits (co-distributed via Massive Photonics), fixable mCLING membrane dyes, control proteins, tissue lysates, affinity resins, and antibody sampler kits. The company also offers custom monoclonal antibody development, single-domain antibody development, antibody production, and antibody labeling services, and operates a wholly-owned subsidiary, NanoTag Biotechnologies (established 2015), which supplies the patented ALFA-Tag nanobody platform.

The business model is direct-to-researcher e-commerce out of Germany at unit prices of roughly $355–$485 for 50–100 µg of purified antibody and approximately $110 for control peptides/proteins, supplemented by an international distributor network. GTM is sales-led through the company website (sysy.com), scientific conferences such as FENS Barcelona, email/newsletter, and organic social channels. Customer segments are horizontal by use case, primarily neuroscience, cancer, immunology, and cell biology researchers in academic and institutional settings. The company differentiates on full in-house production, K.O./K.D. validation, the SYSY Antibodies ATLAS expression-pattern database, and a co-marketing ecosystem with Abberior (super-resolution conjugates) and Massive Photonics (DNA-PAINT kits), and holds ISO 9001:2015 and My Green Lab Platinum certifications.

Name

Synaptic Systems

Legal name

Synaptic Systems GmbH

Website

https://sysy.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

11–50 employees

Short description

Synaptic Systems GmbH is a German research antibody manufacturer founded in 1997 that develops and sells polyclonal, monoclonal, and recombinant antibodies and related reagents under the SYSY Antibodies brand to academic and institutional researchers in neuroscience, cancer, immunology, and cell biology worldwide.

Ownership category

akta.pro rank

Product category

Research Antibodies

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization) (HLAAAIAC), Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)

Keywords

• Research antibody manufacturing
• Monoclonal antibody production
• Neuroscience research reagents
• Recombinant antibody development
• Life science antibodies

Headquarters

HQ city

Göttingen

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Research Antibodies Sales: Sale of primary and secondary antibodies for research applications including neuroscience, cancer research, immunology and cell biology. Products include monoclonal, polyclonal, and recombinant antibodies in various formats (purified IgG, antiserum, affinity purified).

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Synaptic Systems develops, produces, and sells research antibodies and related reagents for life science research. The portfolio includes over 1,900 products such as primary antibodies (monoclonal, polyclonal, recombinant), secondary antibodies, FluoTags single-domain antibodies, DNA-PAINT imaging kits, control proteins, tissue lysates, mCLING membrane dyes, affinity resins, and antibody sampler kits. The company also offers custom antibody development, single-domain antibody development, antibody production, and antibody labeling services to academic and industry researchers.

Product overview

Synaptic Systems (SYSY Antibodies) offers an expanding portfolio of over 1,900 research antibodies and related products for neuroscience, cancer research, immunology, and cell biology. The core product portfolio includes Primary Antibodies (polyclonal, monoclonal, and recombinant formats), Secondary Antibodies, FluoTags/Single Domain Antibodies for advanced imaging applications, DNA-PAINT Imaging Kits for super-resolution microscopy (developed with Massive Photonics GmbH), Control Proteins, Tissue Lysates, mCLING fixable membrane dyes, Affinity Resins, and Antibody Sampler Kits. The company also provides Custom Antibody Service, Single-Domain Antibody Development, Antibody Production, and Antibody Labeling services. Product sub-brands include HistoSure (cancer and immunology research antibodies launched 2017) and products compatible with the ALFA-Tag System (developed by partner company NanoTag Biotechnologies). All products are developed, produced, and rigorously tested in the company's own facilities to ensure highest quality and consistency.

Differentiator

Problem solved

Functional benefit

Products and services

• Primary Antibodies
• Secondary Antibodies
• FluoTags / Single Domain Antibodies
• DNA-PAINT Imaging Kits
• Control Proteins
• Tissue Lysates
• mCLING
• Affinity Resins
• Antibody Sampler Kits
• Custom Antibody Service
• Single-Domain Antibody Development
• Antibody Production
• Antibody Labeling
• HistoSure

Quantifiable outcome

• All antibodies rigorously tested in company's own facilities
• +1 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered core and minor.

• NanoTag BiotechnologiescoreTechnology or Integration · 1 January 2015Synaptic Systems provided venture capital to establish NanoTag Biotechnologies in 2015. NanoTag specializes in camelid single-domain antibodies and developed the patented ALFA-Tag system. Synaptic Systems distributes NanoTag's product portfolio worldwide, including FluoTags and secondary reagents for various immunoassays.
• Max Planck Institute - Department of Molecular Neurobiology (Prof. Nils Brose)coreStrategic or Co-development Partner · 1 January 1997Close cooperation partner since company founding in 1997. Several SYSY Antibodies were developed in their laboratories. The department is at MPI for Multidisciplinary Sciences in Göttingen.
• AbberiorcoreStrategic or Co-development PartnerInnovative leader in advanced fluorescent dyes and microscopes for high-resolution microscopy (STED, MinFLUX, PALM, STORM). Collaboration aims to expand antibody portfolio with new fluorescent conjugates enabling super-resolution microscopy applications.
• Massive Photonics GmbHcoreTechnology or IntegrationMassive Photonics develops and distributes DNA-PAINT Neuro-Imaging Kits. SYSY Antibodies features these kits on their website and refers customers directly to Massive Photonics for these products.
• Department of Cellular Neurophysiology (Prof. Zoltan Nusser)minorStrategic or Co-development PartnerInstitute of Experimental Medicine in Budapest with excellent reputation in immunohistochemistry and electron microscopy. Collaborated on development and validation of several research antibodies.

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• BioLegend: Flow cytometry and immunology-focused antibody vendor acquired by PerkinElmer/Revvity; overlaps with SYSY's HistoSure/immunology catalog and the CD-marker panels (Ly6G, Ly6C, CD25, CD11c) visible in SYSY's July 2025 launch.
• Abcam: Once-independent research antibody pure-play, now part of Danaher; the largest catalog of research antibodies globally with broad coverage including neuroscience. Key competitor for OEM-style antibody sales, though much broader in scope and target breadth than Synaptic Systems.
• Thermo Fisher Scientific (Invitrogen antibodies): Global life sciences conglomerate whose Invitrogen-branded primary and secondary antibodies compete directly across virtually every target Synaptic Systems offers; acts as a scale competitor rather than niche specialist.
• GenScript: China-rooted biotech with an extensive catalog antibody business plus custom antibody services; competes with SYSY's custom mAb and recombinant antibody offerings and ships globally including into Europe and the U.S.
• Merck KGaA / MilliporeSigma: Diversified life science tools and reagents business whose Sigma-Aldrich and Millipore brands supply antibodies alongside a vastly broader chemicals catalog; competes on validation reputation and academic mind-share, especially in German-speaking markets.

Direct peers

• Cell Signaling Technology: Major U.S. research antibody manufacturer with a similarly validated catalog spanning neuroscience, immunology, and cell biology. Most directly comparable peer because of overlapping product categories, focus on validated primary antibodies, and academic-customer base.
• Atlas Antibodies: Swedish antibody company built on the Human Protein Atlas with a flagship 'Triple A Polyclonals' line; very comparable niche positioning with emphasis on IHC-validated primary antibodies and adjacent atlas/database content assets.
• Rockland Immunochemicals: Pennsylvania-based antibody and immunoassay reagent manufacturer of similar size and academic customer base, with comparable catalog, conjugation services, and custom antibody offerings.
• Proteintech: Privately-held antibody manufacturer with a similarly large catalog (>50,000 products) sold direct to academics. Comparable in product model, validation focus, and direct-to-researcher sales motion.
• Santa Cruz Biotechnology: Long-established catalog antibody supplier serving academic and industry researchers with monoclonal, polyclonal, and CRISPR reagent offerings. Closest direct competitor on product breadth, channel model, and customer segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/SynapticSystems
• LinkedInlinkedin.com/company/synaptic-systems-gmbh
• Instagraminstagram.com/sysyantibodies
• Xx.com/synapticsystems

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Synaptic Systems